Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Breadth of neutralising antibody responses to SARS-CoV-2 variants of concern is augmented by vaccination following prior infection: studies in UK healthcare workers and immunodeficient patients

Angalee Nadesalingam, Diego Cantoni, David A Wells, Ernest T Aguinam, Matteo Ferrari, Peter Smith, Andrew Chan, George Carnell, Luis Ohlendorf, View ORCID ProfileSebastian Einhauser, Ralf Wagner, Nigel Temperton, Javier Castillo-Olivares, View ORCID ProfileHelen Baxendale, Jonathan L Heeney, the HICC consortium
doi: https://doi.org/10.1101/2021.06.03.21257901
Angalee Nadesalingam
1Laboratory of Viral Zoonotics, University of Cambridge, CB3 OES, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Diego Cantoni
2Viral Pseudotype Unit, Medway School of Pharmacy, University of Kent, Medway, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David A Wells
1Laboratory of Viral Zoonotics, University of Cambridge, CB3 OES, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ernest T Aguinam
1Laboratory of Viral Zoonotics, University of Cambridge, CB3 OES, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matteo Ferrari
1Laboratory of Viral Zoonotics, University of Cambridge, CB3 OES, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Smith
1Laboratory of Viral Zoonotics, University of Cambridge, CB3 OES, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew Chan
1Laboratory of Viral Zoonotics, University of Cambridge, CB3 OES, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
George Carnell
1Laboratory of Viral Zoonotics, University of Cambridge, CB3 OES, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Luis Ohlendorf
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sebastian Einhauser
4Institute of Medical Microbiology and Hygiene, University Regensburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sebastian Einhauser
Ralf Wagner
3Institute of Clinical Microbiology and Hygiene, University Hospital Regensburg
4Institute of Medical Microbiology and Hygiene, University Regensburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nigel Temperton
2Viral Pseudotype Unit, Medway School of Pharmacy, University of Kent, Medway, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Javier Castillo-Olivares
1Laboratory of Viral Zoonotics, University of Cambridge, CB3 OES, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Helen Baxendale
5Clinical Immunology Department, Royal Papworth NHS Foundation Trust, Cambridge, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Helen Baxendale
Jonathan L Heeney
1Laboratory of Viral Zoonotics, University of Cambridge, CB3 OES, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: jlh66@cam.ac.uk
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Approximately 75% of the UK population has received only one dose of a 2-dose COVID-19 vaccine regime in the face of circulating SARS-CoV-2 Variants of Concern (VOCs). We aimed to determine the levels of vaccine-induced neutralising antibodies to SARS-CoV-2 variants B.1.1.7, B.1.351 and P.1. To do so, we undertook a single-centre cross-sectional study of health care workers (HCWs) and outpatients with immunodeficiencies (IDP) based at the same critical care tertiary NHS Trust, following a single dose of either BNT162b2 or AZD1222 vaccines. Data revealed low neutralising antibodies (nAbs) in IDPs, with only 5% and 3% showing detectable neutralisation of B.1.1.7 and B.1.351, respectively. In contrast, healthy HCWs without a prior SARS-CoV-2 infection demonstrated a wide range of nAb titres post-vaccination with responses significantly lower than HCWs with prior SARS-CoV-2 infection. Neutralisation of VOCs with the E484K mutation (B.1.351 and P.1) were consistently lower in HCWs in the absence of evidence of prior SARS-CoV-2 infection (p<0.001). Notably, in vaccinated HCWs with prior SARS-CoV-2 infection, there was a significant increase of neutralising titres post-vaccination to all variants, compared to their pre-vaccination neutralisation titres. This underscores the importance of vaccination to boost neutralising antibody breadth to VOCs, and also provides support for the hypothesis that repeated immunisations will boost protective immunity in individuals without prior SARS-CoV-2 exposure.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

We thank the RPH Trust and the clinical studies team, HCWs and Outpatients who participated in this study. We also thank members of the HICC consortium. We acknowledge support from Project OVEL (BBSRC, UKRI), the NIHR/UKRI grant, COV0170 Humoral immune Correlates from COVID-19 (HICC) based at the Lab of Viral Zoonotics, University of Cambridge, the Royal Papworth Hospital NHS Trust, and EU FETopen Grant Virofight, (RW, SE).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Study approved by Research Ethics Committee Wales, IRAS: 9619412/WA/0148. Amendment 5

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • All authors declare no competing interests. We thank the RPH Trust and clinical studies team, HCWs and Outpatients who participated in this study. We also thank members of the HICC consortium. We acknowledge support from the NIHR/UKRI grant, COV0170 Humoral immune Correlates from COVID-19 (HICC) based at the Lab of Viral Zoonotics, University of Cambridge, the Royal Papworth Hospital NHS Trust and EU FETopen Grant Virofight, (RW, SE).

Data Availability

All raw data will be made available upon request to corresponding author.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Back to top
PreviousNext
Posted June 06, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Breadth of neutralising antibody responses to SARS-CoV-2 variants of concern is augmented by vaccination following prior infection: studies in UK healthcare workers and immunodeficient patients
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Breadth of neutralising antibody responses to SARS-CoV-2 variants of concern is augmented by vaccination following prior infection: studies in UK healthcare workers and immunodeficient patients
Angalee Nadesalingam, Diego Cantoni, David A Wells, Ernest T Aguinam, Matteo Ferrari, Peter Smith, Andrew Chan, George Carnell, Luis Ohlendorf, Sebastian Einhauser, Ralf Wagner, Nigel Temperton, Javier Castillo-Olivares, Helen Baxendale, Jonathan L Heeney, the HICC consortium
medRxiv 2021.06.03.21257901; doi: https://doi.org/10.1101/2021.06.03.21257901
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Breadth of neutralising antibody responses to SARS-CoV-2 variants of concern is augmented by vaccination following prior infection: studies in UK healthcare workers and immunodeficient patients
Angalee Nadesalingam, Diego Cantoni, David A Wells, Ernest T Aguinam, Matteo Ferrari, Peter Smith, Andrew Chan, George Carnell, Luis Ohlendorf, Sebastian Einhauser, Ralf Wagner, Nigel Temperton, Javier Castillo-Olivares, Helen Baxendale, Jonathan L Heeney, the HICC consortium
medRxiv 2021.06.03.21257901; doi: https://doi.org/10.1101/2021.06.03.21257901

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (227)
  • Allergy and Immunology (501)
  • Anesthesia (110)
  • Cardiovascular Medicine (1233)
  • Dentistry and Oral Medicine (206)
  • Dermatology (147)
  • Emergency Medicine (282)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (529)
  • Epidemiology (10012)
  • Forensic Medicine (5)
  • Gastroenterology (499)
  • Genetic and Genomic Medicine (2448)
  • Geriatric Medicine (236)
  • Health Economics (479)
  • Health Informatics (1636)
  • Health Policy (751)
  • Health Systems and Quality Improvement (635)
  • Hematology (248)
  • HIV/AIDS (532)
  • Infectious Diseases (except HIV/AIDS) (11860)
  • Intensive Care and Critical Care Medicine (625)
  • Medical Education (252)
  • Medical Ethics (74)
  • Nephrology (268)
  • Neurology (2277)
  • Nursing (139)
  • Nutrition (350)
  • Obstetrics and Gynecology (453)
  • Occupational and Environmental Health (534)
  • Oncology (1245)
  • Ophthalmology (375)
  • Orthopedics (133)
  • Otolaryngology (226)
  • Pain Medicine (155)
  • Palliative Medicine (50)
  • Pathology (324)
  • Pediatrics (729)
  • Pharmacology and Therapeutics (311)
  • Primary Care Research (282)
  • Psychiatry and Clinical Psychology (2280)
  • Public and Global Health (4828)
  • Radiology and Imaging (834)
  • Rehabilitation Medicine and Physical Therapy (490)
  • Respiratory Medicine (650)
  • Rheumatology (283)
  • Sexual and Reproductive Health (237)
  • Sports Medicine (226)
  • Surgery (266)
  • Toxicology (44)
  • Transplantation (125)
  • Urology (99)